Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves.
about
Twenty Years of PSA: From Prostate Antigen to Tumor MarkerA first-generation multiplex biomarker analysis of urine for the early detection of prostate cancerProstate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancerA Simple Test Tube-Based ELISA Experiment for the High-School Classroom.Detection of TMPRSS2-ETS fusions by a multiprobe fluorescence in situ hybridization assay for the early diagnosis of prostate cancer: a pilot studyManagement of prostate cancer in port harcourt, Nigeria: changing patterns.Improving the utility of prostate specific antigen (PSA) in the diagnosis of prostate cancer: the use of PSA derivatives and novel markersClinical evaluation of prostate cancer gene 3 score in diagnosis among Chinese men with prostate cancer and benign prostatic hyperplasia.Assessment of intra-individual variation in prostate-specific antigen levels in a biennial randomized prostate cancer screening program in SwedenINNOVATE: A prospective cohort study combining serum and urinary biomarkers with novel diffusion-weighted magnetic resonance imaging for the prediction and characterization of prostate cancerRacial and ethnic variation of PSA in global population: Age specific reference intervals for serum prostate specific antigen in healthy South Indian males.Temporal changes in the clinical approach to diagnosing prostate cancerNovel oncogene-induced metastatic prostate cancer cell lines define human prostate cancer progression signatures.Bridging the gap between biologic, individual, and macroenvironmental factors in cancer: a multilevel approach.Latest tests for prostatic neoplasia.Practice patterns of Korean urologists for screening and managing prostate cancer according to PSA level.Detection rate of prostate cancer following biopsy among the northern Han Chinese population: a single-center retrospective study of 1022 cases.Ten-core versus 16-core transrectal ultrasonography guided prostate biopsy for detection of prostatic carcinoma: a prospective comparative study in Indian population.Prostate cancer detection upon transrectal ultrasound-guided biopsy in relation to digital rectal examination and prostate-specific antigen level: what to expect in the Chinese population?The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men.Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less.Molecular markers for prostate cancer in formalin-fixed paraffin-embedded tissues.Assessment of association between common variants at 17q12 and prostate cancer risk-evidence from Serbian population and meta--analysis.Serum PSA levels in the Indian population: Is it different?Prostate Cancer Screening.
P2860
Q24564782-F9772F54-24AF-4B6D-BFF5-349B05FFFB4CQ24569630-4685FA32-CD28-4927-AE61-6DCDB1FF2F8DQ24645528-78ACDA6A-3335-4B56-9045-2E7270FFD6C8Q34041629-65F0D1FE-7B1D-48E8-BC97-F6FDAD54C311Q34084882-D295168A-21C5-414C-80BF-791D1C4E7AF9Q34555654-9FBE64BF-5624-44E4-ADE5-072D181595DAQ35032198-3A5993C7-4880-4F4C-9CF7-727BDE2AB5EBQ35858216-6B617164-630E-415E-9DB4-C5DCAF99C037Q35948229-01A0E833-CAF2-488B-ABA6-332A452D6E93Q36171334-BA1B5C2A-E9C7-46CF-87F8-B6632BF3465CQ36265000-C6333507-EB97-429E-A2BC-F9207A924094Q36520528-2C13DC4E-E588-41A3-A711-5507F6BA8688Q36580194-463015EE-6257-467E-9EC3-1BF1FE4587F0Q36819754-F010F540-4A0B-40AD-86C9-9F583FABAE1AQ37222117-38FDD364-655E-4B71-AD64-86F1217A05E4Q38052876-9D111AAB-5363-4E20-9D20-4D0212F6013DQ38603373-1A99940E-D881-46BA-9B87-91ECC7F99160Q40162083-8CF34BDF-09E8-4E81-87D2-6EFAF33D1A59Q40255038-07BC4B77-7188-4667-A969-A964D3B6A93AQ41350139-FC51FFB2-C6B7-43D6-9B9F-4A699AF3101EQ41810505-788958B2-A9E3-44D0-8AB0-6EE5A455C2CAQ42184292-5E1F0F3C-75DB-417F-B676-0F02CAE85B98Q42252484-3571321C-296D-4045-89A6-941210088FD7Q47964199-B9D4A449-E878-4FE4-80EF-0F061B787C56Q52698894-CC33E15E-A8E6-4609-ADC7-3E2EA231A961
P2860
Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristic curves.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Selection of optimal prostate ...... erating characteristic curves.
@en
Selection of optimal prostate ...... erating characteristic curves.
@nl
type
label
Selection of optimal prostate ...... erating characteristic curves.
@en
Selection of optimal prostate ...... erating characteristic curves.
@nl
prefLabel
Selection of optimal prostate ...... erating characteristic curves.
@en
Selection of optimal prostate ...... erating characteristic curves.
@nl
P2093
P1476
Selection of optimal prostate ...... perating characteristic curves
@en
P2093
Bruce L Dalkin
Frederick R Ahmann
Jean B DeKernion
Jerome P Richie
Louis R Kavoussi
M'liss A Hudson
Michael T MacFarlane
Paula C Southwick
Peter T Scardino
Robert C Flanigan
P304
P356
10.1016/S0022-5347(17)32300-5
P407
P433
P577
1994-12-01T00:00:00Z